Charron, Giselle

Endogenous morphine-like compound immunoreactivity increases in parkinsonism. [electronic resource] - Brain : a journal of neurology Aug 2011 - 2321-38 p. digital

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

1460-2156

10.1093/brain/awr166 doi


1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine--pharmacology
Aged
Analysis of Variance
Animals
Brain--drug effects
Choline O-Acetyltransferase--metabolism
Chromatography, High Pressure Liquid--methods
Dendrites--metabolism
Disease Models, Animal
Dopamine--metabolism
Dopamine Agents--pharmacology
Dopamine Plasma Membrane Transport Proteins--deficiency
Dopamine and cAMP-Regulated Phosphoprotein 32--metabolism
Enzyme Inhibitors--pharmacology
Enzyme-Linked Immunosorbent Assay--methods
Female
Functional Laterality
Gene Expression Regulation--drug effects
Glial Fibrillary Acidic Protein--metabolism
Glutamate Decarboxylase--metabolism
Humans
Levodopa--pharmacology
Macaca fascicularis
Male
Medial Forebrain Bundle--drug effects
Mice
Mice, Inbred C57BL
Mice, Transgenic
Microscopy, Immunoelectron--methods
Middle Aged
Nerve Growth Factors--metabolism
Organic Chemicals--metabolism
Oxidopamine--adverse effects
Parkinsonian Disorders--chemically induced
Postmortem Changes
Rats
Rats, Sprague-Dawley
Receptors, Dopamine D2--metabolism
S100 Calcium Binding Protein beta Subunit
S100 Proteins--metabolism
Tandem Mass Spectrometry
alpha-Methyltyrosine--pharmacology